{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:25:47Z","timestamp":1790940347646,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1007\/bf02353477","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T21:00:23Z","timestamp":1144357223000},"page":"509-519","source":"Crossref","is-referenced-by-count":63,"title":["N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism"],"prefix":"10.1007","volume":"24","author":[{"given":"Stephen P.","family":"Spielberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1996,10,1]]},"reference":[{"key":"BF02353477_CR1","volume-title":"The Acetylator Genes and Drug Response","author":"W. W. Weber","year":"1987","unstructured":"W. W. Weber.The Acetylator Genes and Drug Response, Oxford University Press, New York, 1987."},{"key":"BF02353477_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0163-7258(89)90036-3","volume":"42","author":"D. A. P. Evans","year":"1989","unstructured":"D. A. P. Evans.N-acetyltransferases.Pharmacol. Ther. 42:157\u2013234 (1989).","journal-title":"Pharmacol. Ther."},{"key":"BF02353477_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199502000-00001","volume":"5","author":"K. P. Vatsis","year":"1995","unstructured":"K. P. Vatsis, W. W. Weber, D. A. Bellet al.. Nomenclature forN-acetyltransferases.Pharmacogenetics 5:1\u201317 (1995).","journal-title":"Pharmacogenetics"},{"key":"BF02353477_CR4","first-page":"266","volume":"70","author":"H. B. Hughes","year":"1954","unstructured":"H. B. Hughes. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.Am. Rev. Tuberculosis 70:266\u2013273 (1954).","journal-title":"Am. Rev. Tuberculosis"},{"key":"BF02353477_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.2.5197.485","volume":"2","author":"D. A. P. Evans","year":"1960","unstructured":"D. A. P. Evans, K. A. Manley, and V. A. McKusick. Genetic control of isoniazid metabolism in man.Br. Med. J. 2:485\u2013491 (1960).","journal-title":"Br. Med. J."},{"key":"BF02353477_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/dna.1990.9.193","volume":"9","author":"M. Blum","year":"1990","unstructured":"M. Blum, D. M. Grant, O. W. McBride, M. Heim, and U. A. Meyer. Human arylamineN-acetyltransferase genes: Isolation, chromosomal localization and functional expression.DNA Cell Biol. 9:193\u2013203 (1990).","journal-title":"DNA Cell Biol."},{"key":"BF02353477_CR7","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1016\/S0021-9258(19)38219-5","volume":"265","author":"T. Deguchi","year":"1990","unstructured":"T. Deguchi, M. Mashimo, and T. Suzuki. Correlation between acetylator phenotypes and genotypes of polymorphic arylamineN-acetyltransferase in human liver.J. Biol. Chem. 265:12757\u201312760 (1990).","journal-title":"J. Biol. Chem."},{"key":"BF02353477_CR8","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1016\/S0021-9258(19)39609-7","volume":"265","author":"S. Ohsako","year":"1990","unstructured":"S. Ohsako and T. Deguchi. Cloning and expression of cDNAs for polymorphic and monomorphic arylamineN-acetyltransferases from human liver.J. Biol. Chem. 265:4630\u20134634 (1990).","journal-title":"J. Biol. Chem."},{"key":"BF02353477_CR9","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1073\/pnas.88.12.5237","volume":"88","author":"M. Blum","year":"1991","unstructured":"M. Blum, A. Demierre, D. M. Grant, H. Heim, and U. A. Meyer. Molecular mechanism of slow acetylation of drugs and carcinogens in humans.Proc. Natl. Acad. Sci. U.S. 88:5237\u20135241 (1991).","journal-title":"Proc. Natl. Acad. Sci. U.S."},{"key":"BF02353477_CR10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0006-2952(91)90282-A","volume":"42","author":"D. Hickman","year":"1991","unstructured":"D. Hickman and E. Sim.N-acetyltransferase polymorphism: Comparison of phenotype and genotype in humans.Biochem. Pharmacol. 42:1007\u20131014 (1991).","journal-title":"Biochem. Pharmacol."},{"key":"BF02353477_CR11","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1073\/pnas.88.14.6333","volume":"88","author":"K. P. Vatsis","year":"1991","unstructured":"K. P. Vatsis, K. J. Martell, and W. W. Weber. Diverse point mutations in the human gene for polymorphicN-acetyltransferase.Proc. Natl. Acad. Sci. U.S. 88:6333\u20136337 (1991).","journal-title":"Proc. Natl. Acad. Sci. U.S."},{"key":"BF02353477_CR12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2125.1984.tb02372.x","volume":"17","author":"D. M. Grant","year":"1984","unstructured":"D. M. Grant, B. K. Tang, and W. Kalow. A simple test for acetylator phenotype using caffeine.Br. J. Clin. Pharmacol. 17:459\u2013464 (1984).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF02353477_CR13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/hmg\/3.5.729","volume":"3","author":"D. Hein","year":"1994","unstructured":"D. Hein, R. Ferguson, M. Dollet al. Molecular genetics of human polymorphicN-acetyltransferase: Enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes.Hum. Mol. Genet. 3:729\u2013734 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"BF02353477_CR14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI114527","volume":"85","author":"D. M. Grant","year":"1990","unstructured":"D. M. Grant, K. Morike, M. Eichelbaum, and U. A. Meyer. Acetylation pharmacogenetics: The slow acetylator phenotype is caused by decreased or absent arylamineN-acetyltransferase in human liver.J. Clin. Invest. 85:968\u2013972 (1990).","journal-title":"J. Clin. Invest."},{"key":"BF02353477_CR15","first-page":"184","volume":"39","author":"D. M. Grant","year":"1991","unstructured":"D. M. Grant, M. Blum, M. Beer, and U. A. Meyer. Monomorphic and polymorphic human arylamineN-acetyltransferases: A comparison of liver isozymes and expressed products of two cloned genes.Mol. Pharmacol. 39:184\u2013191 (1991).","journal-title":"Mol. Pharmacol."},{"key":"BF02353477_CR16","first-page":"244","volume":"3","author":"D. M. Grant","year":"1992","unstructured":"D. M. Grant, P. Vohra, Y. Avis, and A. Ima. Detection of a new polymorphism of humanN-acetyltransferase NAT1 usingp-aminosalicyclic acid as anin vivo probe.J. Basic Clin. Physiol. Pharmacol. 3:244 (1992).","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"BF02353477_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/abbi.1993.1116","volume":"310","author":"K. P. Vatsis","year":"1993","unstructured":"K. P. Vatsis and W. W. Weber. Structural heterogeneity of caucasianN-acetyltransferase at the NAT1 gene locus.Arch. Biochem. Biophys. 310:71\u201376 (1993).","journal-title":"Arch. Biochem. Biophys."},{"key":"BF02353477_CR18","unstructured":"N. Hughes and D. M. Grant. Cloning and expression of new mutant forms of humanN-acetyltransferase NAT1 with defective function.10th International Symposium on Microsomes and Drug Oxidations, Toronto, 1994, p. 278."},{"key":"BF02353477_CR19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/clpt.1993.66","volume":"53","author":"B. L. Lee","year":"1993","unstructured":"B. L. Lee, D. Wong, N. L. Benowitz, and P. M. Sullam. Altered patterns of drug metabolism in patients with the acquired immunodeficiency syndrome.Clin. Pharmacol. Ther. 53:529\u2013535 (1993).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353477_CR20","first-page":"3961","volume":"52","author":"D. M. Grant","year":"1992","unstructured":"D. M. Grant, P. D. Josephy, H. L. Lord, and L. D. Morrison.Salmonella typhimurium strains expressing human arylamineN-acetyltransferases: Metabolic and mutagenic activation of aromatic amines.Cancer Res. 52:3961\u20133964 (1992).","journal-title":"Cancer Res."},{"key":"BF02353477_CR21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/cpt1977223251","volume":"22","author":"D. E. Drayer","year":"1977","unstructured":"D. E. Drayer and M. M. Reidenberg. Clinical consequences of polymorphic acetylation of drugs.Clin. Pharmacol. Ther. 22:251\u2013258 (1977).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353477_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","volume":"105","author":"N. H. Shear","year":"1986","unstructured":"N. H. Shear, S. P. Spielberg, D. M. Grant, B. K. Tang, and W. Kalow. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity.Ann. Intern. Med. 105:179\u2013184 (1986).","journal-title":"Ann. Intern. Med."},{"key":"BF02353477_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.1991.3","volume":"49","author":"M. J. Rieder","year":"1991","unstructured":"M. J. Rieder, N. H. Shear, A. Kanee, B. K. Tang, W. Kalow, and S. P. Spielberg. Predominance of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.Clin. Pharmacol. Ther. 49:13\u201317 (1991).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353477_CR24","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1139\/y85-225","volume":"63","author":"N. H. Shear","year":"1985","unstructured":"N. H. Shear and S. P. Spielberg.In vitro evaluation of a toxic metabolite of sulfadiazine.Can. J. Physiol. Pharmacol. 63:1370\u20131372 (1985).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"BF02353477_CR25","first-page":"784","volume":"18","author":"A. E. Cribb","year":"1990","unstructured":"A. E. Cribb and S. P. Spielberg. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine.Drug. Metab. Disp. 18:784\u2013787 (1990).","journal-title":"Drug. Metab. Disp."},{"key":"BF02353477_CR26","first-page":"744","volume":"38","author":"A. E. Cribb","year":"1990","unstructured":"A. E. Cribb, M. Miller, A. Tesoro, and S. P. Spielberg. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from man and dog.Mol. Pharmacol. 38:744\u2013751 (1990).","journal-title":"Mol. Pharmacol."},{"key":"BF02353477_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1992.8","volume":"51","author":"A. Gupta","year":"1992","unstructured":"A. Gupta, M. M. Eggo, J. P. Uetrechtet al. Drug-induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides.Clin. Pharmacol. Ther. 51:56\u201367 (1992).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353477_CR28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1992.57","volume":"51","author":"A. E. Cribb","year":"1992","unstructured":"A. E. Cribb and S. P. Spielberg. Sulfamethoxazole is metabolized to the hydroxylamine in humans.Clin. Pharmacol. Ther. 51:522\u2013526 (1992).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02353477_CR29","first-page":"406","volume":"23","author":"A. E. Cribb","year":"1995","unstructured":"A. E. Cribb, S. P. Spielberg, and G. P. Griffin.N4-Hydroxylation of sulfamethoxazole by cytochrome P450 of the CYP2C subfamily, and reduction of sulfamethoxazole in human and rat hepatic microsomes.Drug Metab. Disp. 23:406\u2013414 (1995).","journal-title":"Drug Metab. Disp."},{"key":"BF02353477_CR30","first-page":"724","volume":"244","author":"M. J. Rieder","year":"1988","unstructured":"M. J. Rieder, J. P. Uetrecht, and S. P. Spielberg. Synthesis and toxicity of hydroxylamines of the sulfonamides.J. Pharmacol. Exp. Ther. 244:724\u2013728 (1988).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02353477_CR31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.7326\/0003-4819-110-4-286","volume":"110","author":"M. J. Rieder","year":"1989","unstructured":"M. J. Rieder, J. P. Uetrecht, N. H. Shear, M. Cannon, M. Miller, and S. P. Spielberg. Diagnosis of sulfonamide hypersensitivity reactions byin vitro \u201cre-challenge\u201d with hydroxylamine metabolites.Ann. Intern. Med. 110:286\u2013289 (1989).","journal-title":"Ann. Intern. Med."},{"key":"BF02353477_CR32","first-page":"479","volume":"186","author":"U. Giger","year":"1985","unstructured":"U. Giger, L. L. Werner, N. J. Millichamp, and N. T. Gorman. Sulfadiazine-induced allergy in six Doberman Pinschers.J. Am. Vet. Med. Assoc. 186:479\u2013484 (1985).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"BF02353477_CR33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00347744","volume":"14","author":"A. E. Cribb","year":"1990","unstructured":"A. E. Cribb and S. P. Spielberg. Anin vitro investigation of predisposition to sulfonamide idiosyncratic toxicity in dogs.Vet. Res. Commun. 14:241\u2013252 (1990).","journal-title":"Vet. Res. Commun."},{"key":"BF02353477_CR34","first-page":"900","volume":"19","author":"A. E. Cribb","year":"1991","unstructured":"A. E. Cribb, M. A. Miller, J. S. Leeder, and S. P. Spielberg. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione: Implications for idiosyncratic toxicity.Drug Metab. Disp. 19:900\u2013906 (1991).","journal-title":"Drug Metab. Disp."},{"key":"BF02353477_CR35","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0006-2952(91)90334-2","volume":"42","author":"R. Riley","year":"1991","unstructured":"R. Riley, A. E. Cribb, and S. P. Spielberg. Glutathione-S-transferase mu is not a marker for sulfonamide hypersensitivity reactions.Biochem. Pharmacol. 42:696\u2013698 (1991).","journal-title":"Biochem. Pharmacol."},{"key":"BF02353477_CR36","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(89)91909-0","volume":"2","author":"R. Buhl","year":"1989","unstructured":"R. Buhl, H. A. Jaffe, K. J. Holroyd,et al. Systemic glutathione deficiency in symptomfree HIV seropositive individuals.Lancet 2:1294\u20131298 (1989).","journal-title":"Lancet"},{"key":"BF02353477_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","volume":"100","author":"F. M. Gordon","year":"1984","unstructured":"F. M. Gordon, G. L. Simon, C. B. Wofsy, and J. Mills. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.Ann. Intern. Med. 100:495\u2013499 (1984).","journal-title":"Ann. Intern. Med."},{"key":"BF02353477_CR38","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","volume":"323","author":"I. Medina","year":"1990","unstructured":"I. Medina, J. Mills, G. Leounget al. Oral therapy for pneunocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfa-methoxazole vs. trimethoprim-dapsone.New Engl. J. Med. 323:776\u2013782 (1990).","journal-title":"New Engl. J. Med."},{"key":"BF02353477_CR39","first-page":"1099","volume":"274","author":"H. Nakamura","year":"1995","unstructured":"H. Nakamura, J. Uetrecht, D. M. Grant, and S. P. Spielberg. Metabolism and toxicity ofN-acetoxy-sulfamethoxazole.J. Pharmacol. Exp. Ther. 274:1099\u20131104 (1995).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02353477_CR40","first-page":"1241","volume":"259","author":"A. E. Cribb","year":"1991","unstructured":"A. E. Cribb, D. M. Grant, and S. P. Spielberg. Expression of the monomorphic arylamineN-acetyltransferase (NAT1) in human leukocytes.J. Pharmacol. Exp. Ther. 259:1241\u20131246 (1991).","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02353477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02353477\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02353477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T11:17:39Z","timestamp":1627211859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02353477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["BF02353477"],"URL":"https:\/\/doi.org\/10.1007\/bf02353477","relation":{},"ISSN":["0090-466X"],"issn-type":[{"value":"0090-466X","type":"print"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}